Annual Long Term Debt
$4.62 M
-$27.73 M-85.72%
December 31, 2023
Summary
- As of February 8, 2025, PLX annual long term debt is $4.62 million, with the most recent change of -$27.73 million (-85.72%) on December 31, 2023.
- During the last 3 years, PLX annual long term debt has risen by +$154.00 thousand (+3.45%).
- PLX annual long term debt is now -93.59% below its all-time high of $72.10 million, reached on December 31, 2015.
Performance
PLX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$4.18 M
-$106.00 K-2.48%
September 30, 2024
Summary
- As of February 8, 2025, PLX quarterly long term debt is $4.18 million, with the most recent change of -$106.00 thousand (-2.48%) on September 30, 2024.
- Over the past year, PLX quarterly long term debt has dropped by -$326.00 thousand (-7.24%).
- PLX quarterly long term debt is now -96.45% below its all-time high of $117.50 million, reached on March 31, 2017.
Performance
PLX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
PLX Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -85.7% | -7.2% |
| 3 y3 years | +3.5% | -7.2% |
| 5 y5 years | -90.4% | -7.2% |
PLX Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -85.7% | at low | -87.1% | at low |
| 5 y | 5-year | -91.7% | +3.5% | -92.8% | at low |
| alltime | all time | -93.6% | +9547.2% | -96.5% | >+9999.0% |
Protalix BioTherapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.18 M(-2.5%) |
| Jun 2024 | - | $4.28 M(-4.8%) |
| Mar 2024 | - | $4.50 M(-2.6%) |
| Dec 2023 | $4.62 M(-85.7%) | $4.62 M(+2.6%) |
| Sep 2023 | - | $4.50 M(-81.8%) |
| Jun 2023 | - | $24.71 M(-23.8%) |
| Mar 2023 | - | $32.42 M(+0.2%) |
| Dec 2022 | $32.36 M(+0.3%) | $32.36 M(+0.7%) |
| Sep 2022 | - | $32.14 M(+0.7%) |
| Jun 2022 | - | $31.93 M(-0.7%) |
| Mar 2022 | - | $32.16 M(-0.3%) |
| Dec 2021 | $32.26 M(+622.3%) | $32.26 M(+0.0%) |
| Sep 2021 | - | $32.26 M(+615.7%) |
| Jun 2021 | - | $4.51 M(+4.4%) |
| Mar 2021 | - | $4.32 M(-3.3%) |
| Dec 2020 | $4.47 M(-91.9%) | $4.47 M(-92.3%) |
| Sep 2020 | - | $58.06 M(+1.6%) |
| Jun 2020 | - | $57.15 M(+1.6%) |
| Mar 2020 | - | $56.26 M(+1.4%) |
| Dec 2019 | $55.48 M(+15.7%) | $55.48 M(+1.4%) |
| Sep 2019 | - | $54.70 M(+1.3%) |
| Jun 2019 | - | $53.97 M(+1.5%) |
| Mar 2019 | - | $53.17 M(+10.8%) |
| Dec 2018 | $47.97 M | $47.97 M(+1.4%) |
| Sep 2018 | - | $47.32 M(+1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $46.74 M(+1.4%) |
| Mar 2018 | - | $46.11 M(-0.3%) |
| Dec 2017 | $46.27 M(+139.2%) | $46.27 M(-20.1%) |
| Sep 2017 | - | $57.93 M(+0.1%) |
| Jun 2017 | - | $57.88 M(-50.7%) |
| Mar 2017 | - | $117.50 M(+507.5%) |
| Dec 2016 | $19.34 M(-73.2%) | $19.34 M(-73.3%) |
| Sep 2016 | - | $72.43 M(+0.2%) |
| Jun 2016 | - | $72.32 M(+0.2%) |
| Mar 2016 | - | $72.21 M(+0.2%) |
| Dec 2015 | $72.10 M(+7.0%) | $72.10 M(+6.4%) |
| Sep 2015 | - | $67.77 M(+0.2%) |
| Jun 2015 | - | $67.67 M(+0.2%) |
| Mar 2015 | - | $67.57 M(+0.3%) |
| Dec 2014 | $67.35 M(+0.5%) | $67.35 M(-0.0%) |
| Sep 2014 | - | $67.36 M(+0.2%) |
| Jun 2014 | - | $67.25 M(+0.2%) |
| Mar 2014 | - | $67.15 M(+0.2%) |
| Dec 2013 | $67.05 M(>+9900.0%) | $67.05 M(+0.2%) |
| Sep 2013 | - | $66.94 M(+1330.4%) |
| Jun 2012 | - | $4.68 M(+5.1%) |
| Jun 2011 | - | $4.45 M(>+9900.0%) |
| Sep 1999 | - | $36.60 K(-10.3%) |
| Jun 1999 | - | $40.80 K(0.0%) |
| Mar 1999 | - | $40.80 K |
| Dec 1998 | $47.90 K | - |
FAQ
- What is Protalix BioTherapeutics annual long term debt?
- What is the all time high annual long term debt for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual long term debt year-on-year change?
- What is Protalix BioTherapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly long term debt year-on-year change?
What is Protalix BioTherapeutics annual long term debt?
The current annual long term debt of PLX is $4.62 M
What is the all time high annual long term debt for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual long term debt is $72.10 M
What is Protalix BioTherapeutics annual long term debt year-on-year change?
Over the past year, PLX annual long term debt has changed by -$27.73 M (-85.72%)
What is Protalix BioTherapeutics quarterly long term debt?
The current quarterly long term debt of PLX is $4.18 M
What is the all time high quarterly long term debt for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly long term debt is $117.50 M
What is Protalix BioTherapeutics quarterly long term debt year-on-year change?
Over the past year, PLX quarterly long term debt has changed by -$326.00 K (-7.24%)